Oxidized phosphatidylserine–CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells

The phagocytosis of apoptotic cells within an organism is a critical terminal physiological process in programmed cell death. Evidence suggests that apoptotic cell engulfment and removal by macrophages is facilitated by phosphatidylserine (PS) displayed at the exofacial surface of the plasma membrane; however, neither the macrophage receptors responsible for PS recognition, nor characterization of the PS molecular species potentially involved, have been clearly defined. We show that the class B scavenger receptor CD36 plays an essential role in macrophage clearance of apoptotic cells in vivo. Further, macrophage recognition of apoptotic cells via CD36 is shown to occur via interactions with membrane-associated oxidized PS (oxPS) and, to a lesser extent, oxidized phosphatidylcholine, but not nonoxidized PS molecular species. Mass spectrometry analyses of oxPS species identify structures of candidate ligands for CD36 in apoptotic membranes that may facilitate macrophage recognition. Collectively, these results identify oxPS–CD36 interactions on macrophages as potential participants in a broad range of physiologic processes where macrophage-mediated engulfment of apoptotic cells is involved.

[1]  P. Williamson,et al.  Hide and seek: the secret identity of the phosphatidylserine receptor , 2004, Journal of biology.

[2]  R. Murphy,et al.  Electrospray mass spectrometry of phospholipids. , 2003, Mass spectrometry reviews.

[3]  John Savill,et al.  A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.

[4]  Yijun Deng,et al.  Identification of a Novel Family of Oxidized Phospholipids That Serve as Ligands for the Macrophage Scavenger Receptor CD36* , 2002, The Journal of Biological Chemistry.

[5]  S. Hazen,et al.  A Novel Family of Atherogenic Oxidized Phospholipids Promotes Macrophage Foam Cell Formation via the Scavenger Receptor CD36 and Is Enriched in Atherosclerotic Lesions* , 2002, Journal of Biological Chemistry.

[6]  Sten Orrenius,et al.  A Role for Oxidative Stress in Apoptosis: Oxidation and Externalization of Phosphatidylserine Is Required for Macrophage Clearance of Cells Undergoing Fas-Mediated Apoptosis1 , 2002, The Journal of Immunology.

[7]  N. Abumrad,et al.  Role of CD36 in membrane transport of long-chain fatty acids , 2002, Current opinion in clinical nutrition and metabolic care.

[8]  Jihong Han,et al.  Role of CD36, the Macrophage Class B Scavenger Receptor, in Atherosclerosis , 2001, Annals of the New York Academy of Sciences.

[9]  J. Porter,et al.  Missed Opportunities? , 2001, Annals of the New York Academy of Sciences.

[10]  R. Silverstein,et al.  Differential Roles of CD36 and αvβ5 Integrin in Photoreceptor Phagocytosis by the Retinal Pigment Epithelium , 2001, The Journal of experimental medicine.

[11]  V. Fadok,et al.  Apoptotic cell removal , 2001, Current Biology.

[12]  R. Silverstein,et al.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.

[13]  N. Abumrad,et al.  Role of CD36 in membrane transport and utilization of long-chain fatty acids by different tissues , 2001, Journal of Molecular Neuroscience.

[14]  V. Fadok,et al.  Loss of Phospholipid Asymmetry and Surface Exposure of Phosphatidylserine Is Required for Phagocytosis of Apoptotic Cells by Macrophages and Fibroblasts* , 2001, The Journal of Biological Chemistry.

[15]  John Savill,et al.  Corpse clearance defines the meaning of cell death , 2000, Nature.

[16]  S. Hazen,et al.  Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. , 2000, The Journal of clinical investigation.

[17]  T. Saido,et al.  PS-liposome and ox-LDL bind to different sites of the immunodominant domain (#155-183) of CD36: a study with GS95, a new anti-CD36 monoclonal antibody. , 2000, Thrombosis research.

[18]  R. Silverstein,et al.  A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism* , 1999, The Journal of Biological Chemistry.

[19]  S. Hazen,et al.  Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. , 1999, The Journal of clinical investigation.

[20]  J. Tait,et al.  Phosphatidylserine Receptors: Role of CD36 in Binding of Anionic Phospholipid Vesicles to Monocytic Cells* , 1999, The Journal of Biological Chemistry.

[21]  R. Silverstein,et al.  Recombinant Glutathione S-Transferase/CD36 Fusion Proteins Define an Oxidized Low Density Lipoprotein-binding Domain* , 1998, The Journal of Biological Chemistry.

[22]  V. Fadok,et al.  CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). , 1998, Journal of immunology.

[23]  Loise M. Francisco,et al.  Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes , 1998, The Journal of experimental medicine.

[24]  T. Griffith,et al.  Antiinflammatory Effects of CD95 Ligand (FasL)-induced Apoptosis , 1998, Journal of Experimental Medicine.

[25]  M. Greenberg,et al.  The SH3 domain‐binding surface and an acidic motif in HIV‐1 Nef regulate trafficking of class I MHC complexes , 1998, The EMBO journal.

[26]  L. Daviet,et al.  Vascular Biology of CD36: Roles of this New Adhesion Molecule Family in Different Disease States , 1997, Thrombosis and Haemostasis.

[27]  S. Ryeom,et al.  Binding of Anionic Phospholipids to Retinal Pigment Epithelium May Be Mediated by the Scavenger Receptor CD36* , 1996, The Journal of Biological Chemistry.

[28]  L. Daviet,et al.  Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[29]  L. Daviet,et al.  Identification of a Domain (155–183) on CD36 Implicated in the Phagocytosis of Apoptotic Neutrophils* , 1996, The Journal of Biological Chemistry.

[30]  A. Rigotti,et al.  The Class B Scavenger Receptors SR-BI and CD36 Are Receptors for Anionic Phospholipids (*) , 1995, The Journal of Biological Chemistry.

[31]  R. Silverstein,et al.  CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis , 1995, The Journal of experimental medicine.

[32]  L. Stanton,et al.  CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.

[33]  C. Haslett,et al.  Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2 , 1992, Journal of leukocyte biology.

[34]  P. Henson,et al.  Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B. , 1978, Journal of immunology.

[35]  Dmitry Vasunin,et al.  Additional Figures , 1964 .

[36]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[37]  O. Volpert,et al.  Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 , 2000, Nature Medicine.

[38]  S. Hazen,et al.  Erratum: Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species (Journal of Clinical Investigation (2000) 105 (1095-1108)) , 2000 .